Monthly Webinar Series
June 2019
Monthly Webinar Series June 2019 Todays Agenda Announcements - - PowerPoint PPT Presentation
Monthly Webinar Series June 2019 Todays Agenda Announcements & Trial Updates Sandi Cassard Recent Enrollments Christina Grabarits Rowing Competition & Top Enroller Christina Grabarits Best Consent Practices Scott Newsome &
June 2019
Announcements & Trial Updates Sandi Cassard Recent Enrollments Christina Grabarits Rowing Competition & Top Enroller Christina Grabarits Best Consent Practices Scott Newsome & Ellen Mowry Q&A All
SANDI CASSARD
THANK YOU to activated sites for continuing to screen and enroll patients! We have 43 sites activated and 196 patients enrolled as of 5/31/19! Please try to find at least 1 new candidate each week so we can accelerate enrollment!!!
______________________________________________________________________________
1) Beginning this month, VISION will be generating emails to study coordinators each Monday to remind you to address open queries. 2) Responding to queries in a timely manner helps your site and team in the rowboat challenge! 3) Please save and submit for review any page where you have entered data, made a change or responded to a query. Each page that appears “blue” must be submitted for review so the test tube turns “orange” in
THANK YOU for submitting data and uploading source documents promptly!
REMINDER: Mt Everest Survey due by Friday June 7th Shannon Hillery will email the link to the 2 minute survey. Your feedback is extremely valuable in iteratively improving our processes! Thank you for taking the time to fill it out!
*AS OF MONDAY 06/03/19
CHRISTINA GRABARITS
Site Points
136
131
103
102
94
80
76
67
63
61
Rowing Competition
https://treat.preludedynamics.com
May’s Top Performers:
Site Randomizations
Advanced Neurology Specialists 3 University of Alabama at Birmingham 3 Geisinger Clinic 2 University of California at Los Angeles 2 University of Florida Gainesville 2 Norton Neurology 2
May’s Top Enroller: Advanced Neurology Specialists $50
SCOTT NEWSOME ELLEN MOWRY
Recruitment Tip and Trends
The Unexpected Journey Due to Multiple Sclerosis
for people with MS, especially early in the disease course when it may be possible to maximize an individual’s chance for preventing long-term disability.
disability is not clear.
more than others is unknown.
minimizing disability and conversion to secondary progressive MS vs. traditional
and data pooling
A Quick Review
Not a seat-of-the-pants approach Listen to what the high enrollers do
That’s what we need you to do!
motivates people
approved
What clinic coverage do you have?
What schedules and rosters do you have? Who is assigned to reconnoiter? Who is assigned to explain the consent? Who is assigned to follow-up ?
6+ Screens per month 4+ Enrollments per month Recruitment Plan
Base your performance against your census
Robust expectation
per site per year
Use your census numbers to pace your monthly performance
SCREEN IN PERSON DAILY
Talk with your site managers regularly about your census, recruitment activity and capacity
Clinic: Daily/weekly
colleagues who are seeing new patients Clinic: Blitz use of brochures
awareness
awareness
Preview appointment schedules
Notification systems
staff, meetings)
(EMR, MyChart) EMR based methods
existing and add simple trigger)
Coordinated campaign
Fast-paced June goal, needing as much help as possible
The larger team
site
Recruit colleagues to help refer patients Be available at any time Give the patient several methods of contact and get the same from them Early answers lead to enrollment
learning tool
in the study and how to overcome them
understand
consenters on your team
Slow start-up, still waiting for internal logistics, study team, etc.
patients scheduled several months
sooner/when you think trial may be able to launch
strategize how you will catch up, continue to build enthusiasm from referring colleague
schedule to book TREAT-MS patients so can hit ground running
protocol, forms, Vision database
good
Not too many newly-diagnosed patients being seen
guaranteeing fast access for newly- diagnosed appointments (can apply for a really strong referring provider for consideration of named authorship)
residents
to prioritize scheduling newly diagnosed patients with site PI
discuss with patients who may be local “leaders” in MS community
Lack of a single voice in favor of considering the TREAT-MS
referrals
colleagues regularly
will greatly inform THEIR OWN clinical practice in the future in an evidence-based fashion
Site PI doesn’t see any/all new referrals/newly-diagnosed patients
“non-traditional” clinic hours to
IS seeing new patients (remember, s/he may have
Patients seem to want a specific medicine when they come in
equipoise
for consideration of trial
consideration of trial
seriously discussed TREAT-MS!
Meet
Meet weekly to review cases missed
Measure
Measure against the census monthly
Document and review
Document and review what types of exclusions you are seeing and why subjects are declining to participate
Target your goal: Daily discussions in clinic and review of clinic schedules Multimedia: Grand rounds, posters, website, be creative Be precise: Clear and direct messaging Timely and responsive: Meet early Measure results: Meet weekly (we don’t have much time) and track what works
Spread the TREAT-MS Equipoise love Know site specific barriers and consider different workflows/hybrid workflows Work with central schedulers/triage to funnel potential TREAT-MS new patient referrals Consider blocking off time on non-clinic days as extra time goes a long way (perks of “add-on” model) Important to stress no extra visits above what they would do anyway (we tack on the research-specific activities to usual clinical visits) Treating clinician is not exclusive to PI Reach out to colleagues/typically referring clinics (send brochures) Don’t have to complete everything in one visit
A new approach to talking with prospective participants about enrollment in a clinical trial Emphasis on a sequenced approach: Patient/family understanding
Discussion of current standard treatment Possibility of a clinical trial Eder M, Yamokoski A, Wittmann P, Kodish E. Improving informed consent: Suggestions from parents of children with
When a patient said no, what was the reason? Did you know a “no” was coming before it was said? Have you parsed the refusals to develop better talking points?
Sadness/depression Anger Fear Denial
Diagnosis
Shock Unable to process Unknowns Confused Need for more support
Clinical Trial
More people to interact with
Slide courtesy of Jeff Belkora, PhD, UCSF in collaboration with CISN
Family Concerns Financial Worries Treatment Choices Employment Concerns
Diagnosis
Standard vs. Study Confidentiality Risks/Benefits Randomized
Clinical Trial
Slide courtesy of Jeff Belkora, PhD, UCSF in collaboration with CISN
Demands on time Day Care Needs Career demands
Diagnosis
Other Family Commitments Travel Days off Scheduling issues
Clinical Trial
Extra appointments
Slide courtesy of Jeff Belkora, PhD, UCSF in collaboration with CISN
Recognize that there are two elements
Simple terms Impressions are everything! Have a plan and be prepared with materials Sit down! Know the protocol & talking points Take your time
view physicians as more compassionate when they sit
Symptom Management 489 Vol 29 No 5 May 2005
considerable amount of time
the consent process
Provide an empowering environment by inviting the prospective participant to select who will attend this discussion. Increase your prospective participant’s ability to focus on the discussion by holding the meeting in a private location without interruptions. Communicate respect and the importance of this meeting by acknowledging trauma of diagnosis (if appropriate) and empathizing with emotional reactions. Simplify information by avoiding medical jargon and a laundry list of medications and side effects. Summarize
Invite them to make comments or ask questions at any time, and encourage them to share their thoughts and feelings. Tell them that all questions are good questions.
Stress the importance of information-seeking and elicit questions in an open-ended manner. (“What questions do you have?”) Avoid interrupting. Check that questions were answered to your patients’ satisfaction. Talk about how disease treatments have improved over time due to clinical research and participation of patients in clinical trials/studies. Avoid pushing the recommendation of clinical trial at initial encounter, but if asked, respond accordingly.
Follow the sequence of 1) explain disease, 2) describe current best proven treatment, and 3) present option of the clinical trial. Assure that the potential participant has good comprehension of each step before moving to the next one. Break the informed consent conference into two separate meetings if your patient would prefer this or if you think two sessions would help enhance understanding. Use the consent document as a communication tool by providing copies, encouraging reading, and referring to sections of the document during the conference. Discuss treatment options outside of the clinical trial and explain how the study differs from current standard treatment. Explain at least three times that trial participation is voluntary.
Explain the right to withdraw at any time. For randomized trials, use examples to clarify the randomization process and avoid potentially misleading descriptions (for instance, a computer randomly assigns alternative treatments). Use a diagram to show differences among the randomization groups of the trial. Discuss any potential conflict of interest you may have as an investigator. Be prepared to give an answer if the prospective participant asks if you personally would enroll in the trial, or if you would advise one of your family members to enroll.
Open-ended conversations
OPEN
What are your thoughts about the option of entering into the TREAT-MS trial?
CLOSED
Are you interested in learning about the TREAT-MS trial as an
Encore tomorrow at 9 AM EDT!
July’s Monthly Webinar will be held on the 10th at 3 PM and 11th at 9 AM EDT